Senior Manager, Talent Acquisition at Tango Therapeutics

Boston, Massachusetts, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Precision OncologyIndustries

Requirements

Bachelor’s degree; advanced degree preferred
6+ years of progressive full-cycle Talent Acquisition experience, ideally with both agency and sponsor side exposure
4+ years in biotechnology with a successful track record of quality hires ideally across functions from R&D to commercial
Strong business acumen and consultative influence with senior executives, experienced in navigating complex, matrixed environments
Ability to translate business strategy into actionable talent acquisition plans and deliver results
Exceptional market research, headhunting, networking, and sourcing skills
Strong data-driven recruiting skills, including metrics, analytics, and dashboard creation to support evidence-based hiring decisions
Experience creating compelling employer branding campaigns that engage top talent
Skilled in project management of talent acquisition programs, ensuring timely and effective execution
Advanced Excel required

Responsibilities

Drive and support strategic hiring plans across critical domains, aligned with Tango’s growth trajectory and workforce planning
Partner extensively with hiring managers, HR Business Partners, and functional leaders as a strategic talent advisor providing market and talent insights
Leverage talent intelligence and market mapping to identify and engage top talent, building diverse pipelines of active and passive candidates
Optimize recruiting tools, systems, and workflows to improve efficiency, data accuracy, and scalability
Partner with business and HR to continue to embed structured, candidate-centered selection practices that ensure consistent, high-quality hiring decisions and positive experience
Collaborate with the communications team and stakeholders to deliver creative recruitment campaigns and talent attraction initiatives that enhance immediate hiring outcomes and elevate Tango’s employer brand
Represent Tango as an ambassador at industry events, conferences, and networking forums
Track, analyze, and present key hiring metrics to business stakeholders, driving continuous improvement and operational excellence in recruitment practices
Oversee the management of external search firm partnerships for hard-to-fill roles, ensuring quality outcomes within budget in a manner consistent with Tango’s employer brand
Support cross-functional HR initiatives and lead ad hoc projects as needed

Skills

Talent Acquisition

Full-Cycle Recruiting

Strategic Hiring

Workforce Planning

Talent Intelligence

Market Mapping

Employer Branding

Candidate Experience

Tango Therapeutics

Develops targeted cancer therapies using synthetic lethality

About Tango Therapeutics

Tango Therapeutics develops targeted cancer treatments using the principle of synthetic lethality, which allows them to design drugs that kill cancer cells while leaving healthy cells unharmed. Their approach focuses on the interaction between genes, where the loss of both genes leads to cell death, but the loss of only one does not. This method enables them to create therapies that are more precise in targeting tumors. Tango operates in the oncology market, primarily serving healthcare providers and pharmaceutical companies interested in advanced cancer therapies. They collaborate with larger pharmaceutical firms, like Gilead Sciences, to co-develop their treatments, which helps in funding and speeding up the process of bringing these drugs to market. Tango's goal is to advance their pipeline of targeted immunotherapies through strong research and development efforts and strategic partnerships.

Cambridge, MassachusettsHeadquarters

2017Year Founded

$341.4MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

51-200Employees

Benefits

Hybrid Work Options

Risks

Discontinuation of TNG348 due to liver toxicity may affect investor confidence.

Reliance on partnerships for financial support poses risks if partnerships change.

Intensifying competition in precision oncology could impact Tango's market share.

Differentiation

Tango leverages synthetic lethality to target cancer cells while sparing healthy ones.

Their focus includes counteracting tumor suppressor gene loss and immune evasion.

Strategic collaborations with pharma companies accelerate development and commercialization of therapies.

Upsides

Growing interest in synthetic lethality enhances Tango's innovative approach in oncology.

Recent $80 million financing strengthens Tango's financial position for future developments.

FDA clearance for TNG348 and TNG462 boosts Tango's clinical trial advancements.

Land your dream remote job 3x faster with AI

Try Jobo Free